Stock listing
B3:A1SN34 Ascendis Pharma A/S Ações
Brazilian listing (B3) of Ascendis Pharma A/S · home listing NASDAQ:ASND
Follow Ascendis Pharma A/S into a list and get an email when it puts out news.
Share price · BMFBOVESPA:A1SN34
80.64 BRL +4.16 (+5.4%)
Close on Oct 22, 2026
- Day range
- 80.56 – 80.83 BRLOct 22, 2026
- Volume
- 70 sharesOct 22, 2026
- Market cap
- 5.31B BRLAt the close on Oct 22, 2026 · price × 65.80M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ASND · Home | $251.27 USD | -1.73 (-0.7%) | 386,682 | $253.50 | $255.61 | $249.55 | $253.00 | Close on Oct 30, 2026 |
| B3:A1SN34 | 80.64 BRL | +4.16 (+5.4%) | 70 | 80.83 | 80.83 | 80.56 | 76.48 | Close on Oct 22, 2026 |
- Ticker
- B3:A1SN34
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · Oct 26, 2026
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
Latest earnings call · Aug 13, 2026
Ascendis Pharma (NASDAQ:ASND) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Feb 23, 2026
ESG Presentation (February 2026)
Sustainability · 52 slides
Calls
Replays
Ascendis Pharma (NASDAQ:ASND) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 8:00 AM ET
Watch TranscriptAscendis Pharma (NASDAQ:ASND) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:00 AM ET
Watch TranscriptAscendis Pharma (NASDAQ:ASND) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
ESG Presentation (February 2026)
Sustainability · 52 slides · Feb 23, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 30 slides · January 2026
Technical Presentation (October 2025)
Technical · 87 slides · Oct 30, 2025
Technical Presentation (May 2025)
Technical · 84 slides · May 28, 2025
Ascendis Pharma A/S on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in the last 12 months · 59 in all · newest Oct 26, 2026 · oldest 2024
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 13, 2026
- Decks
- 30 decks · latest Feb 23, 2026
Where Ascendis Pharma A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ASND · Home listing | NASDAQ | United States | USD |
| LS Exchange:A14M6X | LS Exchange | Germany | EUR |
| gettex:A710 | gettex | Germany | EUR |
| Lang & Schwarz:A14M6X | Lang & Schwarz | Germany | EUR |
| BOATS:ASND | BOATS | United States | USD |
| B3:A1SN34 · This page | B3 | Brazil | BRL |
| Lang & Schwarz:DK0060606333 | Lang & Schwarz | Germany | EUR |
| BMV:ASNDN | BMV | Mexico | MXN |
| BIVA:ASNDN | BIVA | Mexico | MXN |
| BMV:ASND1N | BMV | Mexico | MXN |
| Tradegate:A710 | Tradegate | Germany | EUR |
| Lang & Schwarz:A42ANJ | Lang & Schwarz | Germany | EUR |
| BIVA:ASND1N | BIVA | Mexico | MXN |
| Dusseldorf:A710 | Dusseldorf | Germany | EUR |
| LS Exchange:A42ANJ | LS Exchange | Germany | EUR |
| Munich:A710 | Munich | Germany | EUR |
| Stuttgart:A710 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascendis Pharma A/S.